2D·

Added a little more

Unfortunately, the play money was lost due to $IINN and $BIOA (+2,17 %) is slowly running out. @Raketentoni But I'm not going to pass up these items for that price.

08.10
Desert Control logo
Comprado a 0,0224 €
14
18 Comentarios

Imagen de perfil
Oh, I’ve got plenty in my portfolio right now, just like @Dividendenopi 😂
The problem is, the market is there, but customers are holding back because of the situation:

Desert Control AS

Sandnes, Norway, October 7, 2026 – Desert Control (OSE: DSRT), a leading company in the field of soil
and water protection technology, announces that it is withdrawing its
previously published revenue guidance for 2026.

The company is withdrawing its outlook because sales cycles
have been prolonged by macroeconomic headwinds in the U.S. agricultural sector and the ongoing
conflict in the Middle East. In addition,
delayed data readings in some pilot projects have prolonged commercial discussions.

"While our record number of customer pilot projects in the first half of 2026 showed very positive results in most cases
and our customers remain engaged in
expansion discussions, major commercial rollouts have been delayed as our
customers have to cope with the significantly increased costs of agricultural inputs, particularly
fertilizers and diesel fuel, and need to gather additional data on the effects of LNC on soil
health and crop yields before making major capital investments during a time of
uncertainty. “LNC is active in the field, and we are seeing treated areas
grow, but unfortunately, the transition to larger contracts has been delayed,”
says James Thomas, CEO of Desert Control. “Overall interest in LNC remains high,
with continued new customer acquisition and the launch of pilot projects."

The company has initiated a review of its sales processes and outlook and expects to provide a detailed business update during its investor update call
scheduled for November 19
.

For further information, please contact:

David Borah

Chief Financial Officer
•
7
•
Imagen de perfil
@Raketentoni Thank you! I'm just enjoying the process, and I'll draw another 1-2 batches by November. Then we'll see how it turns out.
•
1
•
Imagen de perfil
That's not good news. I'd be cautious for now.
••
What makes you believe in the turnaround? The chart looks like a disaster.
••
Imagen de perfil
@Bavarianholder The technology and the partnerships. I think once a few pilot projects are under way, we'll see a resurgence.
•
3
•
@Darkwingduck That's interesting—I'll have to take a closer look at it myself. Thanks! 😊
••
Imagen de perfil
@Bavarianholder Check out my profile—I posted about that stock back then.
🫡
•
4
•
Imagen de perfil
@Darkwingduck I'm still impressed by their technology. But due to a challenging market environment and the lack of a lobbying presence so far, I managed to exit the position in August with a profit thanks to good timing.
•
3
•
Great! I'll check it out later, thanks 😊
••
Imagen de perfil
@MozartsGeist For me, this is risk-taking capital, which accounts for less than 1% of my total portfolio.
•
2
•
Imagen de perfil
@Raketentoni I totally agree with you—don't take any reckless risks! My stake back then was manageable, at less than 0.1% ☺️
•
1
•
Imagen de perfil
I'm at 0.2% and I'm staying in; the loss would be manageable
••
Imagen de perfil
Why did you join " $BIOA "? What convinced you?
••
Imagen de perfil
@Sebbster Feel free to check out Azelaprag :)
••
Imagen de perfil
@Darkwingduck Didn't the company stop doing that in 2025?
••
Imagen de perfil
@Sebbster Yes, but they are continuing their research on certain drugs to develop novel active ingredients. Especially in high-growth markets such as chronic inflammation and obesity.
•
1
•
Imagen de perfil
How much is the dividend?
••
Imagen de perfil
@dirko68 There isn't even a constant revenue or profit so why would there be a dividend?
••
Únase a la conversación